1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ABLIM2 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA MTMR4 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA VMP1 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA ATOX1 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA ZNF48 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA LRRC37A2 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA SYT11 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA AGO3 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA MAST3 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA PALM CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV